Bluejay diagnostics, inc. reports third quarter 2023 financial results

Acton, mass., nov. 09, 2023 (globe newswire) -- bluejay diagnostics, inc. (nasdaq: bjdx) (“bluejay” or the “company”), a clinical-stage medical diagnostics company developing rapid, near-patient tests using whole blood on its symphony platform to improve patient outcomes in critical care settings, today reported its financial results for the quarter and nine months ended september 30, 2023.
BJDX Ratings Summary
BJDX Quant Ranking